-
Signature
-
/s/ Nisha Antony, as Attorney-in-Fact
-
Issuer symbol
-
CRWV
-
Transactions as of
-
02 Feb 2026
-
Net transactions value
-
-$3,195,445
-
Form type
-
4
-
Filing time
-
04 Feb 2026, 21:25:34 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| McBee Brannin |
Chief Development Officer |
C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON |
/s/ Nisha Antony, as Attorney-in-Fact |
04 Feb 2026 |
0002058103 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+1,000 |
|
|
1,000 |
02 Feb 2026 |
Canis Major 2025 Family Trust LLC |
F1, F2 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$17,819 |
-200 |
-20% |
$89.10 |
800 |
02 Feb 2026 |
Canis Major 2025 Family Trust LLC |
F2, F3, F4 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$46,020 |
-509 |
-64% |
$90.41 |
291 |
02 Feb 2026 |
Canis Major 2025 Family Trust LLC |
F2, F3, F5 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$23,318 |
-255 |
-88% |
$91.44 |
36 |
02 Feb 2026 |
Canis Major 2025 Family Trust LLC |
F2, F3, F6 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$1,671 |
-18 |
-50% |
$92.84 |
18 |
02 Feb 2026 |
Canis Major 2025 Family Trust LLC |
F2, F3 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$1,704 |
-18 |
-100% |
$94.65 |
0 |
02 Feb 2026 |
Canis Major 2025 Family Trust LLC |
F2, F3 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+1,000 |
|
|
1,000 |
02 Feb 2026 |
Canis Minor 2025 Family Trust LLC |
F1, F7 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$17,819 |
-200 |
-20% |
$89.10 |
800 |
02 Feb 2026 |
Canis Minor 2025 Family Trust LLC |
F3, F4, F7 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$46,021 |
-509 |
-64% |
$90.41 |
291 |
02 Feb 2026 |
Canis Minor 2025 Family Trust LLC |
F3, F5, F7 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$23,318 |
-255 |
-88% |
$91.44 |
36 |
02 Feb 2026 |
Canis Minor 2025 Family Trust LLC |
F3, F6, F7 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$1,671 |
-18 |
-50% |
$92.84 |
18 |
02 Feb 2026 |
Canis Minor 2025 Family Trust LLC |
F3, F7 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$1,704 |
-18 |
-100% |
$94.65 |
0 |
02 Feb 2026 |
Canis Minor 2025 Family Trust LLC |
F3, F7 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+25,000 |
|
|
25,000 |
02 Feb 2026 |
Canis Major 2025 GRAT |
F1, F8 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$464,135 |
-5,213 |
-21% |
$89.03 |
19,787 |
02 Feb 2026 |
Canis Major 2025 GRAT |
F3, F8, F9 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$747,151 |
-8,284 |
-42% |
$90.19 |
11,503 |
02 Feb 2026 |
Canis Major 2025 GRAT |
F3, F8, F10 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$885,478 |
-9,724 |
-85% |
$91.06 |
1,779 |
02 Feb 2026 |
Canis Major 2025 GRAT |
F3, F8, F11 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$130,632 |
-1,422 |
-80% |
$91.87 |
357 |
02 Feb 2026 |
Canis Major 2025 GRAT |
F3, F8, F12 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$25,917 |
-279 |
-78% |
$92.89 |
78 |
02 Feb 2026 |
Canis Major 2025 GRAT |
F3, F8, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$7,361 |
-78 |
-100% |
$94.37 |
0 |
02 Feb 2026 |
Canis Major 2025 GRAT |
F3, F8, F14 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+8,335 |
|
|
8,335 |
02 Feb 2026 |
Canis Minor 2025 GRAT |
F1, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$154,831 |
-1,739 |
-21% |
$89.03 |
6,596 |
02 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F9, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$249,111 |
-2,762 |
-42% |
$90.19 |
3,834 |
02 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F10, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$295,220 |
-3,242 |
-85% |
$91.06 |
592 |
02 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F11, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$43,452 |
-473 |
-80% |
$91.86 |
119 |
02 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F12, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$8,639 |
-93 |
-78% |
$92.89 |
26 |
02 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F13, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$2,453 |
-26 |
-100% |
$94.35 |
0 |
02 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F14, F15 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-1,000 |
-0.9% |
|
110,600 |
02 Feb 2026 |
Class A Common Stock |
1,000 |
|
Canis Major 2025 Family Trust LLC |
F1, F2 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-1,000 |
-0.8% |
|
124,000 |
02 Feb 2026 |
Class A Common Stock |
1,000 |
|
Canis Minor 2025 Family Trust LLC |
F1, F7 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-25,000 |
-0.43% |
|
5,750,000 |
02 Feb 2026 |
Class A Common Stock |
25,000 |
|
Canis Major 2025 GRAT |
F1, F8 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-8,335 |
-0.9% |
|
916,650 |
02 Feb 2026 |
Class A Common Stock |
8,335 |
|
Canis Minor 2025 GRAT |
F1, F15 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
This Form 4 is Part 2 of 2 for this reporting person. Transactions by the reporting person are continued on this Part 2.